Evidence map›Paper›PMID 19422851›Full record

ReviewPharmacology & therapeutics2009

Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Will C McClatchey, Gail B Mahady, Bradley C Bennett, Laura Shiels, Valentina Savo

Abstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Nutrients · 2022
    Article
  8. Antibiofilm Potential of Medicinal Plants againstAntibiotics (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Article
  11. Ethnobotanical research in Cava de' Tirreni area, Southern Italy.Journal of ethnobiology and ethnomedicine · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Ritual drinks in the pre-Hispanic US Southwest and Mexican Northwest.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Article
  18. Phylogenies reveal predictive power of traditional medicine in bioprospecting.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  19. Local knowledge: who cares?Journal of ethnobiology and ethnomedicine · 2011
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Will C McClatcheyDepartment of Botany, University of Hawai;i at Manoa, Honolulu, HI 96822, USA. mcclatch@hawaii.edu
Gail B Mahady
Bradley C Bennett
Laura Shiels
Valentina Savo

Funding

Van Breemen: Project 3; Botanical Dietary Supplements - Metabolism and Safety in Women (Van Breemen)P50AT000155 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PAULI, GUIDO F · 1999 to 2019
$30.4M
Theaflavins and Gallic Acid in TeaS06GM008205 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI BIGGER, CHARLES H · 1989 to 2008
$17.6M
Training in Alternative Tropical Botanical MedicineT32AT001060 · NCCIH · FLORIDA INTERNATIONAL UNIVERSITY · PI BENNETT, BRADLEY C · 2001 to 2005
$1.3M
EVALUATION OF BOTANICALS FOR H .PYLORI INFECTIONSR21AT000412 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAHADY, GAIL B · 2001 to 2002
$388k
NCCIH NIH HHS P50 AT000155NCCIH NIH HHS R21 AT000412NCCIH NIH HHS T32 AT001060NIGMS NIH HHS S06 GM008205
6 · The paper itself

Abstract

The science of ethnobotany is reviewed in light of its multi-disciplinary contributions to natural product research for the development of pharmaceuticals and pharmacological tools. Some of the issues reviewed involve ethical and cultural perspectives of healthcare and medicinal plants. While these are not usually part of the discussion of pharmacology, cultural concerns potentially provide both challenges and insight for field and laboratory researchers. Plant evolutionary issues are also considered as they relate to development of plant chemistry and accessing this through ethnobotanical methods. The discussion includes presentation of a range of CNS-active medicinal plants that have been recently examined in the field, laboratory and/or clinic. Each of these plants is used to illustrate one or more aspects about the valuable roles of ethnobotany in pharmacological research. We conclude with consideration of mutually beneficial future collaborations between field ethnobotanists and pharmacologists.

Indexed as

Biological ProductsEthnobotanyPlants, MedicinalResearchCentral Nervous System AgentsBiological ProductsCentral Nervous System Agents

Identifiers

PMID19422851
PMCPMC2700180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.